281 related articles for article (PubMed ID: 34376308)
1. From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years.
Phillips A; Carlson S; Danchin M; Beard F; Macartney K
Vaccine; 2021 Sep; 39(40):5968-5981. PubMed ID: 34376308
[TBL] [Abstract][Full Text] [Related]
2. Active SMS-based influenza vaccine safety surveillance in Australian children.
Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021.
Glover C; Deng L; Larter C; Brogan C; Richardson O; Huang YA; Kay E; Macartney K; Wood N
Commun Dis Intell (2018); 2024 Jun; 48():. PubMed ID: 38926650
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
[TBL] [Abstract][Full Text] [Related]
5. Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia.
Pillsbury AJ; Glover C; Jacoby P; Quinn HE; Fathima P; Cashman P; Leeb A; Blyth CC; Gold MS; Snelling T; Macartney KK
BMJ Open; 2018 Oct; 8(10):e023263. PubMed ID: 30341132
[TBL] [Abstract][Full Text] [Related]
6. Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study.
Jacoby P; Glover C; Damon C; Fathima P; Pillsbury A; Durrheim D; Gold MS; Leeb A; Snelling T
BMJ Open; 2020 Mar; 10(2):e031851. PubMed ID: 32122906
[TBL] [Abstract][Full Text] [Related]
7. Vaccine safety in Australia during the COVID-19 pandemic: Lessons learned on the frontline.
Laemmle-Ruff I; Lewis G; Clothier HJ; Dimaguila GL; Wolthuizen M; Buttery J; Crawford NW
Front Public Health; 2022; 10():1053637. PubMed ID: 36408022
[TBL] [Abstract][Full Text] [Related]
8. The Pendulum Has Swung: How Do We Ensure a Life Course Approach to Immunisation in Australia?
Seale H; McFadden K; Dyda A; Kaufman J; Heywood A
Front Public Health; 2021; 9():801176. PubMed ID: 35186875
[TBL] [Abstract][Full Text] [Related]
9. The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal.
Chan NN; Ong KW; Siau CS; Lee KW; Peh SC; Yacob S; Chia YC; Seow VK; Ooi PB
BMC Public Health; 2022 Feb; 22(1):296. PubMed ID: 35164734
[TBL] [Abstract][Full Text] [Related]
10. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
[TBL] [Abstract][Full Text] [Related]
11. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
[TBL] [Abstract][Full Text] [Related]
12. The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia.
King C; Leask J
BMC Public Health; 2017 Jan; 17(1):106. PubMed ID: 28114986
[TBL] [Abstract][Full Text] [Related]
13. Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older.
Pillsbury AJ; Fathima P; Quinn HE; Cashman P; Blyth CC; Leeb A; Macartney KK
JAMA Netw Open; 2020 May; 3(5):e204079. PubMed ID: 32369177
[TBL] [Abstract][Full Text] [Related]
14. Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015.
Pillsbury A; Cashman P; Leeb A; Regan A; Westphal D; Snelling T; Blyth C; Crawford N; Wood N; Macartney K;
Euro Surveill; 2015; 20(43):. PubMed ID: 26536867
[TBL] [Abstract][Full Text] [Related]
15. Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: A pharmacovigilance analysis using WHO international database.
Kim MS; Jung SY; Ahn JG; Park SJ; Shoenfeld Y; Kronbichler A; Koyanagi A; Dragioti E; Tizaoui K; Hong SH; Jacob L; Salem JE; Yon DK; Lee SW; Ogino S; Kim H; Kim JH; Excler JL; Marks F; Clemens JD; Eisenhut M; Barnett Y; Butler L; Ilie CP; Shin EC; Il Shin J; Smith L
J Med Virol; 2022 Mar; 94(3):1085-1095. PubMed ID: 34709664
[TBL] [Abstract][Full Text] [Related]
16. Active vaccine safety surveillance of seasonal influenza vaccination via a scalable, integrated system in Western Australian pharmacies: a prospective cohort study.
Salter S; Singh G; Nissen L; Trentino K; Murray K; Lee K; Kop B; Peters I; Leeb A
BMJ Open; 2021 Jun; 11(6):e048109. PubMed ID: 34103321
[TBL] [Abstract][Full Text] [Related]
17. Does a major change to a COVID-19 vaccine program alter vaccine intention? A qualitative investigation.
Carlson SJ; McKenzie L; Roberts L; Blyth CC; Attwell K
Vaccine; 2022 Jan; 40(4):594-600. PubMed ID: 34952758
[TBL] [Abstract][Full Text] [Related]
18. ATAGI Targeted Review 2021: the national COVID-19 vaccination program.
Jayasinghe S; Patel C; Armstrong L; Chiu C; Macartney K; Flanagan K; Gibney K; Giles M; Crawford N; Cheng A; Blyth C
Commun Dis Intell (2018); 2023 Apr; 47():. PubMed ID: 37106451
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study.
Allen K; Lambert SB; Yuen A; Pourmarzi D
BMC Public Health; 2022 Nov; 22(1):2205. PubMed ID: 36443806
[TBL] [Abstract][Full Text] [Related]
20. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
